University of Kansas
CRIOs and their equivalents often are asked to bridge academic and provider sides of institutions to support clinical trials and data analytics with massive research datasets.
Core labs remain closed or at reduced operations due to the COVID-19 pandemic, leading to concerns about the state of their businesses when they can reopen.
The team will present the results to the US Food and Drug Administration as part of a 510(k) application in order to commercialize the technology with Biofluidica.
With several SBIR grants from the NIH, the firm is also using its Liquid Scan platform to identify neonatal trophoblast cells in maternal blood samples.
Research groups and companies are developing and applying tools to enrich for and capture CTCs to diagnose tumors early and monitor patients during treatment.